Document is current
Any future updates will be listed below
-
Authors
Pardi, Norbert
Weissman, Drew https://orcid.org/0000-0002-1501-6510
-
Funding
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (AI146101, AI153064)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01-AI124429)
- License Information
-
More Information
Article History
First Online: 8 December 2020
Competing interests
: The authors are named on patents (20170327842, 10,232,055, 20180303925) that describe the use of nucleoside-modified mRNA as a platform to deliver therapeutic proteins and vaccines. These competing interests have been fully disclosed to the University of Pennsylvania, and an approved plan for managing any potential conflicts arising from the licensing of the patents is in place.
Free to read: This content has been made available to all.
